Comparing two pre-surgery treatments for older adults with rectal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study compares two approaches to treating rectal cancer in people age 70 and older who have not yet had surgery. One approach gives chemotherapy and radiation before surgery, and the other adds more chemotherapy after radiation. The goal is to find which plan works better with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 70 or older.
- You have a type of rectal cancer called adenocarcinoma that is stage II (high-risk) or stage III and can be removed with surgery.
- You haven't had any previous treatment for rectal cancer.
- Your cancer has not spread to other parts of the body (no metastases).
- Your organs (kidneys, liver, bone marrow) are working well enough to handle treatment.
- You do not have conditions like serious heart problems, nerve damage, or a rare genetic deficiency that would make treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different radiation regimens (long-course vs. short-course) combined with chemotherapy (CAPOX), an immunotherapy drug (PD-1 antibody), and a COX-2 inhibitor for people with MSS locally advanced rectal cancer. The goal is to see which approach works better in shrinking the tumor before surgery.
This study tests a sequence of chemotherapy and radiation before and after surgery for rectal cancer. It compares giving more chemo between the end of radiation and surgery (consolidation) versus giving some chemo before radiation starts (induction). The goal is to see which order works better.
This trial tests a stronger chemo combination (FOLFOXIRI) versus the standard ones (CAPOX or FOLFOX), both followed by chemoradiation, then surgery or a watch-and-wait approach for people with high-risk locally advanced rectal cancer. The goal is to see which approach works better at preventing the cancer from coming back.
This trial compares two treatment plans for older adults with locally advanced rectal cancer to see which one works better and is safer. It tests a full course of chemotherapy and radiation before surgery versus a shorter approach.
This trial compares two treatment approaches for stage II (T3) rectal cancer: chemoradiation before surgery versus a total neoadjuvant therapy approach (chemotherapy and radiation) before surgery. It aims to find which is more effective and safer.
This trial tests whether a full course of chemotherapy and radiation before any surgery (called total neoadjuvant therapy) can help you avoid surgery and preserve your rectum. It is for people with a specific early stage of rectal cancer that has not spread.
Hear when a new Locally Advanced Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.